Effect of camelid B7-H3 tri-specific killer engagers on natural killer cells in patients with prostate cancer.
Nicholas A. Zorko(University of Minnesota Medical Center), Jeffrey S. Miller(Science Museum of Minnesota), Gwen Phung(University of Minnesota), Yvette Soignier(University of Minnesota System), Amanda J. Russell(University of Minnesota), Martin Felices(University of Minnesota), Peter Hinderlie(University of Minnesota), Asha J. Bozicevich(University of Minnesota System), Melissa Khaw(University of Minnesota), Laura E. Bendzick(University of Minnesota), Laura E. Kotz(University of Minnesota), Jacobi Rugloski(University of Minnesota), Justin H. Hwang(University of Minnesota), Joshua T. Walker(University of Minnesota System), Madison Shackelford(University of Minnesota System), Emmanuel S. Antonarakis(University of Minnesota)
Cited by 1
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
|Blood|2013|537